Compare Cronos Group Inc (CRON) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Oracle Corporation — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Oracle Corporation trades at $129.99 (market cap $368.53B). The key difference: Oracle Corporation is far larger — about 361.3× Cronos Group Inc's market cap, and Oracle Corporation pays a 1.56% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | ORCL | |
|---|---|---|
Market Cap | $1.02B | $368.53B |
Sector | Health | Technology |
52-Week High | $3.27 | $328.33 |
52-Week Low | $1.95 | $127.96 |
Enterprise Value | $203.29M | $497.78B |
Dividend Yield | — | 1.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Oracle (ORCL) trades at $131.86, down 6.27% in the last 24 hours, amid a bearish technical signal but strong fundamental performance. The company reported revenue of $57.40B in 2025 with a net income margin of 25.37%, and has beaten earnings estimates for the last three quarters. Recent news highlights Oracle's AI infrastructure growth and a pending Q2 2026 earnings report on June 10, 2026.
The outlook for Oracle is positive due to robust earnings growth and AI-driven opportunities, though risks include high debt levels and competitive pressures. Analysts maintain a bullish consensus with a $259 price target, suggesting significant upside from the current price if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
